Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related LncRNAs

Overview

Journal Front Genet

Date 2022 Aug 8

PMID 35938013

Authors

Xiayao Diao

Chao Guo

Shanqing Li

Affiliations

Soon will be listed here.

Abstract

Long non-coding RNAs (lncRNAs) are drawing increasing attention as promising predictors of prognosis for lung adenocarcinoma (LUAD) patients. Necroptosis, a novel regulated mechanism of necrotic cell death, plays an important role in the biological process of cancer. The aim of this study was to identify the necroptosis-related lncRNAs (NRLRs) in a LUAD cohort and establish a necroptosis-related lncRNA signature (NRLSig) to stratify LUAD patients. NRLRs were identified in LUAD patients from The Cancer Genome Atlas (TCGA) database using Pearson correlation analysis between necroptosis-related genes and lncRNAs. Then the NRLSig was identified using univariate Cox regression analysis and LASSO regression analysis. Assessments of the signature were performed based on survival analysis, receiver operating characteristic (ROC) curve analysis and clustering analysis. Next, a nomogram containing the NRLSig and clinical information was developed through univariate and multivariate Cox regression analysis. Further, functional enrichment analysis of the selected lncRNAs in NRLSig and the association between NRLSig and the immune infiltration were also evaluated. A 4-lncRNA signature, incorporating LINC00941, AP001453.2, AC026368.1, and AC236972.3, was identified to predict overall survival (OS) and stratify LUAD patients into different groups. Survival analysis, ROC curve analysis and clustering analysis showed good performance in the prognostic prediction of the lncRNA signature. Then, a nomogram containing the NRLSig was developed and showed satisfactory predictive accuracy, calibration and clinical usefulness. The co-expressed genes of selected NRLRs were enriched in several biological functions and signaling pathways. Finally, differences in the abundance of immune cells were investigated among the high-risk group and low-risk group divided by the NRLSig. The proposed NRLSig may provide promising therapeutic targets or prognostic predictors for LUAD patients.

Citing Articles

Targeting necroptosis: a promising avenue for respiratory disease treatment.

Cao X, Tan J, Zheng R, Wang F, Zhou L, Yi J Cell Commun Signal. 2024; 22(1):418.

PMID: 39192326 PMC: 11350980. DOI: 10.1186/s12964-024-01804-6.

The fate and function of non-coding RNAs during necroptosis.

Bozgeyik E, Elek A, Gocer Z, Bozgeyik I Epigenomics. 2024; 16(11-12):901-915.

PMID: 38884366 PMC: 11370912. DOI: 10.1080/17501911.2024.2354653.

References

Zhao Z, Liu H, Zhou X, Fang D, Ou X, Ye J . Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer. J Oncol. 2021; 2021:6718443. PMC: 8592775. DOI: 10.1155/2021/6718443. View

Sanchez-Esteban J, Wang Y, Filardo E, Rubin L, Ingber D . Integrins beta1, alpha6, and alpha3 contribute to mechanical strain-induced differentiation of fetal lung type II epithelial cells via distinct mechanisms. Am J Physiol Lung Cell Mol Physiol. 2005; 290(2):L343-50. DOI: 10.1152/ajplung.00189.2005. View

Wang L, Zhao H, Xu Y, Li J, Deng C, Deng Y . Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma. Int J Cancer. 2018; 144(7):1723-1734. DOI: 10.1002/ijc.31865. View

Johnstone R, Ruefli A, Lowe S . Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002; 108(2):153-64. DOI: 10.1016/s0092-8674(02)00625-6. View

Agostini M, Ganini C, Candi E, Melino G . The role of noncoding RNAs in epithelial cancer. Cell Death Discov. 2020; 6:13. PMC: 7067833. DOI: 10.1038/s41420-020-0247-6. View

Stoll G, Ma Y, Yang H, Kepp O, Zitvogel L, Kroemer G . Pro-necrotic molecules impact local immunosurveillance in human breast cancer. Oncoimmunology. 2017; 6(4):e1299302. PMC: 5414877. DOI: 10.1080/2162402X.2017.1299302. View

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H . The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22(9):1775-89. PMC: 3431493. DOI: 10.1101/gr.132159.111. View

Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J . Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020; 13(1):110. PMC: 7418434. DOI: 10.1186/s13045-020-00946-7. View

Mollaoglu G, Jones A, Wait S, Mukhopadhyay A, Jeong S, Arya R . The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 2018; 49(4):764-779.e9. PMC: 6197489. DOI: 10.1016/j.immuni.2018.09.020. View

10.

Miller V, Hirsh V, Cadranel J, Chen Y, Park K, Kim S . Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial. Lancet Oncol. 2012; 13(5):528-38. DOI: 10.1016/S1470-2045(12)70087-6. View

11.

Brady J, Chuang C, Greenside P, Rogers Z, Murray C, Caswell D . An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency. Cancer Cell. 2016; 29(5):697-710. PMC: 4864124. DOI: 10.1016/j.ccell.2016.03.003. View

12.

Remijsen Q, Goossens V, Grootjans S, Van den Haute C, Vanlangenakker N, Dondelinger Y . Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis. 2014; 5:e1004. PMC: 4040672. DOI: 10.1038/cddis.2013.531. View

13.

Yao J, Chen X, Liu X, Li R, Zhou X, Qu Y . Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma. Cancer Cell Int. 2021; 21(1):340. PMC: 8254945. DOI: 10.1186/s12935-021-02027-2. View

14.

Hung C, Wang L, Yu Y, Chen H, Srivastava S, Petrovics G . A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014; 111(52):18697-702. PMC: 4284533. DOI: 10.1073/pnas.1415669112. View

15.

Paolillo M, Schinelli S . Extracellular Matrix Alterations in Metastatic Processes. Int J Mol Sci. 2019; 20(19). PMC: 6802000. DOI: 10.3390/ijms20194947. View

16.

Meza R, Meernik C, Jeon J, Cote M . Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. PLoS One. 2015; 10(3):e0121323. PMC: 4379166. DOI: 10.1371/journal.pone.0121323. View

17.

Pan G, Liu Y, Shang L, Zhou F, Yang S . EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond). 2021; 41(3):199-217. PMC: 7968884. DOI: 10.1002/cac2.12138. View

18.

Yusof K, Rosli R, Abdullah M, Avery-Kiejda K . The Roles of Non-Coding RNAs in Tumor-Associated Lymphangiogenesis. Cancers (Basel). 2020; 12(11). PMC: 7694641. DOI: 10.3390/cancers12113290. View

19.

Ren M, Chen S, Wang L, Rui W, Li P . LINC00941 Promotes Progression of Non-Small Cell Lung Cancer by Sponging miR-877-3p to Regulate VEGFA Expression. Front Oncol. 2021; 11:650037. PMC: 8044452. DOI: 10.3389/fonc.2021.650037. View

20.

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View